| 1 |
35442150 | Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study. | 2022 Apr 20 |
2 |
| 2 |
34161878 | New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies. | 2021 Sep |
1 |
| 3 |
34609748 | Evaluation of a new series of pyrazole derivatives as a potent epidermal growth factor receptor inhibitory activity: QSAR modeling using quantum-chemical descriptors. | 2021 Dec 15 |
1 |
| 4 |
31212178 | Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors. | 2019 Sep |
1 |
| 5 |
29571113 | Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. | 2018 Aug |
1 |
| 6 |
30218747 | Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells. | 2018 Dec 30 |
4 |
| 7 |
28487127 | Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma. | 2017 Jun 15 |
1 |
| 8 |
26548551 | 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA. | 2015 |
2 |
| 9 |
23937232 | Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents. | 2013 Nov |
1 |
| 10 |
20627597 | Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. | 2010 Jul 1 |
1 |